Scott Michael Habig, Chief Commercial Officer at Aurinia Pharmaceuticals Inc. (AUPH), bought 5,000 shares at $5.02 ($25K) on 2022-11-09, disclosed to the SEC on 2022-11-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| AUPH | SELL | 2024-02-22 | $174K | — | Filing → |